Keyrus

Corporate VC Levallois-Perret, France · Founded 2014

Keyrus Ventures is the corporate venture capital arm of Keyrus Group, investing in early-stage startups that shape the future of Data, AI, and digital transformation.

About Keyrus

Keyrus is a French global data and digital consulting firm rather than a venture fund, with selective strategic equity investments in technology companies that complement its consulting practice in data analytics, AI, and digital transformation. Healthcare exposure is partial and concentrated where Keyrus has consulting client relationships, including pharma analytics, life sciences digital, and selectively provider analytics. AI focus is meaningful in the consulting practice and welcome in equity investments where AI is core to the product. Plausible check sizes for strategic investments are EUR 500K to EUR 5M, typically as a strategic co-investor or partnership investment rather than a financial lead. Founders best suited are post-product Series A and B CEOs in data analytics, AI for life sciences, or healthcare data infrastructure, who would benefit from a strategic partner with deep client relationships in pharma and life sciences and global consulting reach. Founders who do not fit include consumer wellness, devices, therapeutics, and digital health services without a data or analytics angle. Geographic preference is global with a French and European bias. The entry path is warm introduction through a Keyrus consulting executive, a portfolio CEO, or a French data analytics operator. LinkedIn outreach to a Keyrus business development or strategic investment leader with a clear partnership thesis is a reasonable secondary option. Founders should treat Keyrus primarily as a consulting partner and channel for life sciences clients rather than as a primary venture investor, and pair any strategic investment with a financial lead. Expect partnership-oriented conversations and structured client introduction commitments alongside any equity discussion.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Keyrus

Tools made by companies in Keyrus's portfolio that we cover in the directory.

AUTION EYE AI-4510 Urine Particle Analysis
Arkray
Lab & Diagnostics
The AUTION EYE AI-4510 is a fully automated urine particle analyzer by Arkray, utilizing AI-powered digital imaging and a proprietary algorithm to classify 12 types of formed elements in urine, streamlining laboratory workflow and enhancing diagnostic accuracy.

Portfolio companies in our directory

Other portfolio companies

Companies in Keyrus's portfolio not currently in our directory.

Team

Eric Cohen
Founder, Chairman and Chief Executive Officer of Keyrus Group

Pitch / review this investor

Have you raised from Keyrus? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.